Home Cart Sign in  
Chemical Structure| 593960-11-3 Chemical Structure| 593960-11-3

Structure of PIK-93
CAS No.: 593960-11-3

Chemical Structure| 593960-11-3

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

PIK-93 is the potent, synthetic PI4K (PI4KIIIβ) inhibitor with IC50 of 19 nM, and shown to inhibit PI3Kα with IC50 of 39 nM.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of PIK-93

CAS No. :593960-11-3
Formula : C14H16ClN3O4S2
M.W : 389.88
SMILES Code : CC(NC1=NC(C)=C(C2=CC=C(Cl)C(S(=O)(NCCO)=O)=C2)S1)=O
MDL No. :MFCD12922510
InChI Key :JFVNFXCESCXMBC-UHFFFAOYSA-N
Pubchem ID :6852167

Safety of PIK-93

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H317-H319
Precautionary Statements:P280-P305+P351+P338

Related Pathways of PIK-93

PI3K-AKT

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
H1975 cells 1 μM 24 h PIK-93 significantly reduced PD-L1 expression in H1975 cells with little cytotoxicity. PMC10081850
M1 macrophages 10 μM 24 h PIK-93 reduced PD-L1 expression on M1 macrophages and enhanced their tumor-killing function. PMC10081850
HEK293 cells 10 µM 24 h To identify the cellular target of PIK-93 through siRNA screening, results showed that PIK-93 inhibits PV replication by targeting PI4KB activity. PMC3067798
RD cells 10 µM 7 h To evaluate the inhibitory effect of PIK-93 on PV pseudovirus infection, results showed that PIK-93 significantly inhibited PV pseudovirus infection. PMC3067798
A7r5 cells 300 nM 20 min PIK-93 inhibits PI3K, reducing vasopressin-induced translocation of TRPC6 to the plasma membrane and calcium influx. PMC3366789
T6.11 cells 300 nM 20 min PIK-93 inhibits PI3K, reducing carbachol-induced translocation of TRPC6 to the plasma membrane and calcium influx. PMC3366789
DA neurons 250 nM 24 h Reduced DA neuronal loss and partially rescued backward locomotion defects PMC5599522

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Mice CT26 syngeneic mouse model Intraperitoneal injection 60 mg/kg Once every other day for 2 weeks Combined PIK-93 and anti–PD-L1 antibody treatment significantly inhibited tumor growth and increased tumor-infiltrating lymphocyte recruitment. PMC10081850
C. elegans Vpr-1 knockdown model Liquid culture 250 nM Daily supplementation until Day 10 Reduced DA neuronal loss and partially rescued backward locomotion defects PMC5599522
C. elegans Vpr-1 knockdown model Liquid culture 250 nM Supplemented every 24 h until the end of the experiment PIK-93 significantly reduced the frequency of DA neuronal loss caused by the knockdown of vpr-1 in these neurons and partially rescued the backward locomotion defect, suggesting that inhibiting PtdIns4P synthesis can delay neuronal loss. PMC5599522

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.56mL

0.51mL

0.26mL

12.82mL

2.56mL

1.28mL

25.65mL

5.13mL

2.56mL

References

 

Historical Records

Categories